TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

Rosen Law Firm alerts DexCom investors about a securities class action lawsuit alleging unauthorized design changes to glucose monitoring systems that potentially compromised device reliability and user safety.

Insights
DXCM   negative

Lawsuit claims the company made unauthorized design changes to G6 and G7 continuous glucose monitoring systems, potentially creating health risks and exposing the company to regulatory scrutiny, legal challenges, and reputational damage